Increased osteoprotegerin levels in women with previous gestational diabetes developing metabolic syndrome

Bentley-Lewis, 2009, Late cardiovascular consequences of gestational diabetes mellitus, Semin Reprod Med, 27, 322, 10.1055/s-0029-1225260 Carpenter, 2007, Gestational diabetes, pregnancy hypertension, and late vascular disease, Diabetes Care, 30, S246, 10.2337/dc07-s224 Akinci, 2009, Prediction of developing metabolic syndrome after gestational diabetes mellitus, Fertil Steril Reece, 2009, Gestational diabetes: the need for a common ground, Lancet, 373, 1789, 10.1016/S0140-6736(09)60515-8 Simonet, 1997, Osteoprotegerin: a novel secreted protein involved in the regulation of bone density, Cell, 89, 309, 10.1016/S0092-8674(00)80209-3 Anderson, 1997, A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function, Nature, 390, 175, 10.1038/36593 Kong, 1999, OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis, Nature, 397, 315, 10.1038/16852 Browner, 2001, Associations of serum osteoprotegerin levels with diabetes, stroke, bone density, fractures, and mortality in elderly women, J Clin Endocrinol Metab, 86, 631, 10.1210/jc.86.2.631 Kiechl, 2004, Osteoprotegerin is a risk factor for progressive atherosclerosis and cardiovascular disease, Circulation, 109, 2175, 10.1161/01.CIR.0000127957.43874.BB Van Campenhout, 2009, Osteoprotegerin, vascular calcification and atherosclerosis, Atherosclerosis, 204, 321, 10.1016/j.atherosclerosis.2008.09.033 Abedin, 2007, Relation of osteoprotegerin to coronary calcium and aortic plaque (from the Dallas heart study), Am J Cardiol, 99, 513, 10.1016/j.amjcard.2006.08.064 Akinci, 2008, Serum osteoprotegerin is associated with carotid intima media thickness in women with previous gestational diabetes, Diabetes Res Clin Pract, 82, 172, 10.1016/j.diabres.2008.07.014 Madarasz, 2009, Osteoprotegerin levels in women with prior gestational diabetes mellitus, Diabetes Care, 32, e5, 10.2337/dc08-1628 Coustan, 1985, Detection and treatment of gestational diabetes, Clin Obstet Gynecol, 28, 507, 10.1097/00003081-198528030-00006 Grundy, 2005, Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Executive summary, Cardiol Rev, 13, 322, 10.1097/01.crd.0000380842.14048.7e Avignon, 2005, Osteoprotegerin is associated with silent coronary artery disease in high-risk but asymptomatic type 2 diabetic patients, Diabetes Care, 28, 2176, 10.2337/diacare.28.9.2176 Golledge, 2004, Osteoprotegerin and osteopontin are expressed at high concentrations within symptomatic carotid atherosclerosis, Stroke, 35, 1636, 10.1161/01.STR.0000129790.00318.a3 Omland, 2008, Circulating osteoprotegerin levels and long-term prognosis in patients with acute coronary syndromes, J Am Coll Cardiol, 51, 627, 10.1016/j.jacc.2007.09.058 Xiang, 2006, The relationship between plasma osteoprotegerin and endothelium-dependent arterial dilation in type 2 diabetes, Diabetes, 55, 2126, 10.2337/db06-0231 Shargorodsky, 2009, Osteoprotegerin as an independent marker of subclinical atherosclerosis in osteoporotic postmenopausal women, Atherosclerosis, 204, 608, 10.1016/j.atherosclerosis.2008.10.024 Kim, 2005, Serum osteoprotegerin levels are associated with inflammation and pulse wave velocity. Clin Endocrinol (Oxf), 63, 594 Jung, 2009, The relationship between coronary artery calcification score, plasma osteoprotegerin level and arterial stiffness in asymptomatic type 2 DM, Acta Diabetol Ueland, 2004, Prognostic value of osteoprotegerin in heart failure after acute myocardial infarction, J Am Coll Cardiol, 44, 1970, 10.1016/j.jacc.2004.06.076 Anand, 2006, The relationship between plasma osteoprotegerin levels and coronary artery calcification in uncomplicated type 2 diabetic subjects, J Am Coll Cardiol, 47, 1850, 10.1016/j.jacc.2005.12.054 Yaturu, 2008, Relationship of elevated osteoprotegerin with insulin resistance, CRP, and TNF-alpha levels in men with type 2 diabetes, Cytokine, 44, 168, 10.1016/j.cyto.2008.07.471 Olesen, 2005, Arterial osteoprotegerin: increased amounts in diabetes and modifiable synthesis from vascular smooth muscle cells by insulin and TNF-alpha, Diabetologia, 48, 561, 10.1007/s00125-004-1652-8 Jorgensen, 2009, Acute hyperinsulinemia decreases plasma osteoprotegerin with diminished effect in type 2 diabetes and obesity, Eur J Endocrinol, 161, 95, 10.1530/EJE-09-0141 Xiang, 2007, Changes of osteoprotegerin before and after insulin therapy in type 1 diabetic patients, Diabetes Res Clin Pract, 76, 199, 10.1016/j.diabres.2006.09.008 Ugur-Altun, 2007, Circulating leptin and osteoprotegerin levels affect insulin resistance in healthy premenopausal obese women, Arch Med Res, 38, 891, 10.1016/j.arcmed.2007.04.013 Golledge, 2008, Determinants of endothelial function in a cohort of patients with peripheral artery disease, Cardiology, 111, 51, 10.1159/000113428 Gannage-Yared, 2006, Circulating osteoprotegerin is correlated with lipid profile, insulin sensitivity, adiponectin and sex steroids in an ageing male population, Clin Endocrinol (Oxf), 64, 652, 10.1111/j.1365-2265.2006.02522.x Nabipour, 2009, Osteoprotegerin in relation to type 2 diabetes mellitus and the metabolic syndrome in postmenopausal women, Metabolism Mazziotti, 2006, Increased serum osteoprotegerin values in long-lived subjects: different effects of inflammation and bone metabolism, Eur J Endocrinol, 154, 373, 10.1530/eje.1.02099 Asanuma, 2007, Serum osteoprotegerin is increased and independently associated with coronary-artery atherosclerosis in patients with rheumatoid arthritis, Atherosclerosis, 195, e135, 10.1016/j.atherosclerosis.2007.04.049 Min, 2000, Osteoprotegerin reverses osteoporosis by inhibiting endosteal osteoclasts and prevents vascular calcification by blocking a process resembling osteoclastogenesis, J Exp Med, 192, 463, 10.1084/jem.192.4.463 Price, 2001, Osteoprotegerin inhibits artery calcification induced by warfarin and by vitamin D, Arterioscler Thromb Vasc Biol, 21, 1610, 10.1161/hq1001.097102 Bucay, 1998, Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification, Genes Dev, 12, 1260, 10.1101/gad.12.9.1260 Van Campenhout, 2007, Serum osteoprotegerin as a biomarker for vascular disease, Am J Cardiol, 100, 561, 10.1016/j.amjcard.2007.03.023